PMID: 28589097    eFIP  1    Check other iTextMine results Issue Report


Title
1.AGO2 Negatively Regulates Type I Interferon Signaling Pathway by Competition Binding IRF3 with CBP/p300.
Abstract
6.AGO2 did not block phosphorylation, nuclear translocation, and DNA binding ability of IRF3 but inhibited its association with CBP.
Loading...

Loading data

Legend:   SUBSTRATE  KINASE  INTERACTANT  SITE  GENE  MIRNA  ANOMALY  EXPRESSION  DISEASE  OUTCOME/RESPONSE  SR_DRUG  DRUG  CELL  TRIGGER  Normalized

Tool: eFIP

PTM enzymeSubstrateSiteImpactInteractantSentence
IRF3 (Q14653)inhibitedCBP (Q92793)6